This paper proposes a method of remotely controlling robots with arm gestures using surface electromyography(EMG)and accelerometer sensors attached to the operator's wrists.The EMG and accelerometer sensors receiv...This paper proposes a method of remotely controlling robots with arm gestures using surface electromyography(EMG)and accelerometer sensors attached to the operator's wrists.The EMG and accelerometer sensors receive signals from the arm gestures of the operator and infer the corresponding movement to execute the command to control the robot.The movements of the robot include moving forward and backward and turning left and right.The forearm of the robot can be rotated up,down,left and right,and the robot can clench its fists.The accuracy is over 99% and movements can be controlled in real time.展开更多
This study is to investigate the changes of back muscle electromyography (EMG) in occupational low back pain (LBP) patients pre-and post-rehabilitation.20 occupational LBP patients were asked to perform sepcially desi...This study is to investigate the changes of back muscle electromyography (EMG) in occupational low back pain (LBP) patients pre-and post-rehabilitation.20 occupational LBP patients were asked to perform sepcially designed symmetrical and asymmetrical actions,which include"carrying"weights up and down with a 45° left rotation.Back muscle EMG signals were recorded from surface of paraspinal muscles.The tests performed in the weeks immediately before and after 12-week rehabilitation treatment.The profile and mean power frequency (MPF) of EMG were compared between pre-and post-rehabilitation.EMG profiles showed unchangeable,but the MPF showed significantly increase in post-rehabilitation comparing to pre-rehabilitation.That suggested that the muscle activity strategies could not be modified by rehabilitation,but the rehabilitation would increase the threshold of fatigue and reduce the possible muscle pain in back paraspinal muscles.展开更多
Botulinum toxin type A is a potent muscle relaxant that blocks the transmission and release of acetylcholine at the neuromuscular junction. Intramuscular injection of botulinum toxin type A has served as an effective ...Botulinum toxin type A is a potent muscle relaxant that blocks the transmission and release of acetylcholine at the neuromuscular junction. Intramuscular injection of botulinum toxin type A has served as an effective and safe therapy for strabismus and focal dystonia. However, muscular weakness is temporary and after 3-4 months, muscle strength usually recovers because function- al recovery is mediated by nerve sprouting and reconstruction of the neuromuscular junction. Acrylamide may produce neurotoxic substances that cause retrograde necrotizing neuropathy and inhibit nerve sprouting caused by botulinum toxin type A. This study investigated whether acrylamide inhibits nerve sprouting after intramuscular injection of botulinum toxin type A. A tibial nerve sprouting model was established through local injection of botulinum toxin type A into the right gastrocnemius muscle of Sprague-Dawley rats. Following intramuscular injection, rats were given intraperitoneal injection of 3% acrylamide every 3 days for 21 days. Nerve sprout- ing appeared 2 weeks after intramuscular injection of botulinum toxin type A and single-fiber electromyography revealed abnormal conduction at the neuromuscular junction I week after intra- muscular injection of botulinum toxin type A. Following intraperitoneal injection of acrylamide, the peak muscle fiber density decreased. Electromyography jitter value were restored to normal levels 6 weeks after injection. This indicates that the maximal decrease in fiber density and the time at which functional conduction of neuromuscular junction was restored were delayed. Addition- ally, the increase in tibial nerve fibers was reduced. Acrylamide inhibits nerve sprouting caused by botulinum toxin type A and may be used to prolong the clinical dosage of botulinum toxin type A.展开更多
基金The MKE(The Ministry of Knowledge Economy),Korea,under the ITRC(Infor mation Technology Research Center)support programsupervised by the NIPA(National ITIndustry Promotion Agency)(NIPA-2012-H0301-12-2006)
文摘This paper proposes a method of remotely controlling robots with arm gestures using surface electromyography(EMG)and accelerometer sensors attached to the operator's wrists.The EMG and accelerometer sensors receive signals from the arm gestures of the operator and infer the corresponding movement to execute the command to control the robot.The movements of the robot include moving forward and backward and turning left and right.The forearm of the robot can be rotated up,down,left and right,and the robot can clench its fists.The accuracy is over 99% and movements can be controlled in real time.
文摘This study is to investigate the changes of back muscle electromyography (EMG) in occupational low back pain (LBP) patients pre-and post-rehabilitation.20 occupational LBP patients were asked to perform sepcially designed symmetrical and asymmetrical actions,which include"carrying"weights up and down with a 45° left rotation.Back muscle EMG signals were recorded from surface of paraspinal muscles.The tests performed in the weeks immediately before and after 12-week rehabilitation treatment.The profile and mean power frequency (MPF) of EMG were compared between pre-and post-rehabilitation.EMG profiles showed unchangeable,but the MPF showed significantly increase in post-rehabilitation comparing to pre-rehabilitation.That suggested that the muscle activity strategies could not be modified by rehabilitation,but the rehabilitation would increase the threshold of fatigue and reduce the possible muscle pain in back paraspinal muscles.
基金supported by TCM General Research Project of Zhejiang Province,No.2014ZA071Health General Research Project of Zhejiang Province,No.2014KYA106
文摘Botulinum toxin type A is a potent muscle relaxant that blocks the transmission and release of acetylcholine at the neuromuscular junction. Intramuscular injection of botulinum toxin type A has served as an effective and safe therapy for strabismus and focal dystonia. However, muscular weakness is temporary and after 3-4 months, muscle strength usually recovers because function- al recovery is mediated by nerve sprouting and reconstruction of the neuromuscular junction. Acrylamide may produce neurotoxic substances that cause retrograde necrotizing neuropathy and inhibit nerve sprouting caused by botulinum toxin type A. This study investigated whether acrylamide inhibits nerve sprouting after intramuscular injection of botulinum toxin type A. A tibial nerve sprouting model was established through local injection of botulinum toxin type A into the right gastrocnemius muscle of Sprague-Dawley rats. Following intramuscular injection, rats were given intraperitoneal injection of 3% acrylamide every 3 days for 21 days. Nerve sprout- ing appeared 2 weeks after intramuscular injection of botulinum toxin type A and single-fiber electromyography revealed abnormal conduction at the neuromuscular junction I week after intra- muscular injection of botulinum toxin type A. Following intraperitoneal injection of acrylamide, the peak muscle fiber density decreased. Electromyography jitter value were restored to normal levels 6 weeks after injection. This indicates that the maximal decrease in fiber density and the time at which functional conduction of neuromuscular junction was restored were delayed. Addition- ally, the increase in tibial nerve fibers was reduced. Acrylamide inhibits nerve sprouting caused by botulinum toxin type A and may be used to prolong the clinical dosage of botulinum toxin type A.
